IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

MENZAGHI, BARBARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.207
EU - Europa 1.836
AS - Asia 1.710
SA - Sud America 153
AF - Africa 79
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.993
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.117
SG - Singapore 500
CN - Cina 459
IT - Italia 443
GB - Regno Unito 378
DE - Germania 345
VN - Vietnam 194
HK - Hong Kong 173
SE - Svezia 127
RU - Federazione Russa 125
BR - Brasile 114
BD - Bangladesh 112
FR - Francia 81
IN - India 80
NL - Olanda 76
CA - Canada 70
IE - Irlanda 58
FI - Finlandia 54
TR - Turchia 53
CI - Costa d'Avorio 45
UA - Ucraina 36
ID - Indonesia 29
KR - Corea 28
DK - Danimarca 21
JP - Giappone 18
AR - Argentina 16
BE - Belgio 13
PL - Polonia 13
CO - Colombia 11
ES - Italia 10
IQ - Iraq 10
PH - Filippine 10
EU - Europa 9
UZ - Uzbekistan 8
AT - Austria 7
AU - Australia 7
ZA - Sudafrica 7
CH - Svizzera 6
MX - Messico 6
LT - Lituania 5
RO - Romania 5
GR - Grecia 4
IR - Iran 4
MA - Marocco 4
OM - Oman 4
PT - Portogallo 4
VE - Venezuela 4
AL - Albania 3
AZ - Azerbaigian 3
BG - Bulgaria 3
CU - Cuba 3
ET - Etiopia 3
KE - Kenya 3
LU - Lussemburgo 3
LY - Libia 3
NA - Namibia 3
NO - Norvegia 3
PA - Panama 3
PK - Pakistan 3
TN - Tunisia 3
TW - Taiwan 3
CL - Cile 2
CY - Cipro 2
DZ - Algeria 2
EE - Estonia 2
EG - Egitto 2
HR - Croazia 2
IL - Israele 2
JM - Giamaica 2
KZ - Kazakistan 2
LK - Sri Lanka 2
NI - Nicaragua 2
PY - Paraguay 2
RS - Serbia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
GH - Ghana 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
JO - Giordania 1
LB - Libano 1
MD - Moldavia 1
MT - Malta 1
MY - Malesia 1
NG - Nigeria 1
NP - Nepal 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
Totale 5.998
Salva come PNG Salva come JPEG
Città #
Southend 317
Singapore 305
Ashburn 284
Chandler 188
Frankfurt am Main 175
Dallas 168
San Jose 157
Hong Kong 148
Milan 138
Fairfield 108
Beijing 75
Seattle 63
New York 59
Ann Arbor 57
Dublin 57
Santa Clara 57
Ho Chi Minh City 56
Wilmington 55
Woodbridge 52
Council Bluffs 51
Los Angeles 48
Abidjan 45
Hanoi 45
Houston 42
Princeton 42
Toronto 41
Boardman 39
Hanover 37
Cambridge 36
Rome 36
Helsinki 32
Istanbul 30
Dearborn 27
Bengaluru 25
Jacksonville 25
Phoenix 25
Lauterbourg 24
Hefei 23
Moscow 23
Shanghai 22
Buffalo 21
Guangzhou 19
Jakarta 18
Munich 17
Da Nang 14
Des Moines 14
Fuzhou 14
Nanjing 14
Bologna 13
Brussels 13
Cangzhou 13
Chicago 13
Haiphong 13
Seoul 13
London 12
Nuremberg 12
Ottawa 12
São Paulo 12
Tokyo 12
Warsaw 12
Kent 11
Palermo 11
Shenzhen 11
Atlanta 10
Columbus 10
Mumbai 10
Naples 10
Redmond 10
The Dalles 10
Tianjin 9
Andover 8
Bogotá 8
Dong Ket 8
Lappeenranta 8
Orem 8
Turku 8
Wuhan 8
Central District 7
Changsha 7
Hangzhou 7
Kunming 7
San Diego 7
Turin 7
Amsterdam 6
Catania 6
Chennai 6
City of London 6
Fremont 6
Jinan 6
Montreal 6
Mountain View 6
Redwood City 6
Rio de Janeiro 6
Sakarya 6
Serra 6
Tashkent 6
Utrecht 6
Washington 6
Baghdad 5
Belo Horizonte 5
Totale 3.818
Salva come PNG Salva come JPEG
Nome #
Improvement of ALT decay kinetics by all-oral HCV treatment : role of NS5A inhibitors and differences with IFN-based regimens 342
Safety of statin therapy in HIV/hepatitis C virus-coinfected patients 314
Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: Results from a large multicentre observational prospective cohort (SCOLTA) 310
Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort 309
Vpr and HIV-1 disease progression : R77Q mutation is associated with long-term control of HIV-1 infection in different groups of patients 293
Effect of Antioxidants on Mitochondrial Function in HIV-1-Related Lipoatrophy : A Pilot Study 275
Altered expression of the tetraspanin CD81 on B and T lymphocytes during HIV-1 infection 269
Burden of Disease in PWH Harboring a Multidrug-Resistant Virus: Data from the PRESTIGIO Registry 267
Patient-Reported Outcomes in an Observational Cohort of HIV-1-Infected Adults on Darunavir/Cobicistat-Based Regimens: Beyond Viral Suppression 265
Optimal efficacy of interferon-free HCV retreatment after protease inhibitor failure in real life 250
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 234
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C 230
Chronic coinfection with hepatitis B and hepatitis C viruses in an Italian population of HIV-infected patients 227
Dysmetabolism, Diabetes and Clinical Outcomes in Patients Cured of Chronic Hepatitis C: A Real-Life Cohort Study 218
The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort 215
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting 205
Renal safety in 3264 HCV patients treated with DAA-based regimens : results from a large Italian real-life study 188
Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulation 182
Metabolic syndrome and body weight in people living with HIV infection: analysis of differences observed in three different cohort studies over a decade 179
Effectiveness of dolutegravir-based vs boosted darunavir-based first-line 3-drug regimens in people with HIV with advanced dimalsease: a trial emulation 171
The good and evil of flare: flares in hepatitis B virus chronic hepatitis 167
Treatment of 320 genotype 3 cirrhotic patients with 12 weeks Sofosbuvir/Velpatasvir with or without ribavirin: real life experience from Italy 162
Effectiveness of first-line lamivudine/dolutegravir antiretroviral therapy in persons with HIV: real-life data from the ICONA Foundation cohort 134
Proportion of newly diagnosed persons with HIV with HIV-RNA greater than/equal to 500,000 copies/mL in 2018-2023 in Italy: data from the ICONA Foundation Cohort Study 124
Comorbidities and HCV coinfection in the management of HIV+ patients: Evidence from the Italian clinical practice 124
HIV infection among adolescents and young adults in Italy: epidemiology, viro-immunological and treatment outcomes 112
Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational Study 111
Correction to: Patient-Reported Outcomes in an Observational Cohort of HIV-1-Infected Adults on Darunavir/Cobicistat-Based Regimens: Beyond Viral Suppression 103
Real-life safety of Emtricitabine/Tenofovir Alafenamide/Bictegravir 95
Lipids and Body Mass Index in Antiretroviral-Experienced People With HIV on Doravirine-Based Treatments: A Comparison Between Dual or Triple Regimen Versus Bictegravir-Based Triple Regimen 54
Evaluation of HIV-1 DNA resistance evolution in highly treatment-experienced and multi-resistant individuals under suppressive antiretroviral therapy: a longitudinal study from the PRESTIGIO Registry 50
Totale 6.179
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.803
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.803
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202130 0 0 0 0 0 0 0 0 0 0 0 30
2021/2022418 12 18 26 20 12 12 38 56 76 60 17 71
2022/2023512 55 78 38 73 47 63 6 30 70 7 39 6
2023/2024452 14 24 34 33 101 48 38 33 13 32 43 39
2024/2025845 40 77 20 93 60 45 41 65 49 99 76 180
2025/20262.662 212 191 272 260 216 162 383 142 240 225 275 84
Totale 6.179